BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24844223)

  • 1. PAX1 methylation as a potential biomarker for cervical cancer screening.
    Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
    Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
    J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
    Gao Y; Zi D; Liang W; Qiu F; Zheng J; Xiao X; Jiang E; Xu Y
    Acta Cytol; 2024; 68(2):137-144. PubMed ID: 38527422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time colorimetric detection of DNA methylation of the
    Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
    Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
    Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
    Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
    Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
    Wang ZM
    Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
    Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
    Chang CC; Huang RL; Wang HC; Liao YP; Yu MH; Lai HC
    Int J Gynecol Cancer; 2014 Feb; 24(2):201-9. PubMed ID: 24407576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
    Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
    BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
    Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
    Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
    Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
    Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
    Liu H; Meng X; Wang J
    Int J Gynecol Cancer; 2020 Oct; 30(10):1488-1492. PubMed ID: 32616628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
    Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
    Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
    Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
    Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
    Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
    Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.